Zacks Investment Research on MSN
Pfizer's non-oncology portfolio in focus ahead of Q1 earnings
Pfizer PFE is scheduled to report its first-quarter 2026 results on May 5, with investor focus firmly on its oncology ...
Pfizer, by contrast, appears diversified but diffuse—its pipeline may contain value, but that value is not yet organized into ...
WASHINGTON -- A CDC advisory panel is set to convene in an emergency meeting next week to discuss reports of heart inflammation in adolescents who received the COVID-19 vaccine. CDC says 226 confirmed ...
During an early May meeting, the European Medicines Agency’s safety committee concluded two reviews of safety signals related to COVID-19 vaccines, while it continued following other vaccine-related ...
WASHINGTON (AP) — U.S. government advisers on Monday reiterated that Pfizer’s COVID-19 vaccine is safe and effective for people 16 and older. The vaccine was the first to win full approval in the U.S.
The health ministry is preparing to recommend males in their teens and 20s get the Pfizer COVID-19 vaccine instead of Moderna ...
ATLANTA -- The US Food and Drug Administration added a warning about the risk of myocarditis and pericarditis to fact sheets for Moderna and Pfizer-BioNTech COVID-19 vaccines Friday. The warning notes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results